Dobutamine

Overview

4.6 out of 5 (25 Reviews)

Credits

1.00

Post Assessment Questions

7

Start Date

1 Sep 2023

Last Review Date

23 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Dobutamine is approved by the US Food and Drug Administration (FDA) for short-term use in patients with decreased contractility due to heart failure or cardiac procedures resulting in cardiac decompensation. Despite its ability to improve hemodynamics, dobutamine has not shown positive outcomes for heart failure patients in either the hospital or outpatient setting.

In patients experiencing cardiogenic shock, short-term intravenous (IV) inotropic support with dobutamine is administered to sustain systemic blood flow and shield against end-organ damage. This off-label use of dobutamine serves as a transient measure until patients can undergo more definitive treatments such as coronary revascularization, mechanical circulatory support, or heart transplant. This activity highlights the FDA-approved indications, off-label uses, mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of dobutamine pertinent to interprofessional healthcare team members involved in treating patients with cardiac disorders or aiming to attain hemodynamic stability. 


UAN: JA4008338-0000-23-1490-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate indications for dobutamine therapy in patients with decreased contractility due to heart failure or cardiac procedures.

  • Implement proper dosing protocols and infusion rate adjustments based on patient response and clinical status.

  • Select appropriate monitoring parameters to track the effectiveness and safety of dobutamine therapy to optimize patient outcomes while minimizing risks.

  • Collaborate with the interprofessional healthcare teams to verify dosing, check for drug interactions, and address any concerns related to dobutamine administration, ensuring continuity and optimal outcomes.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-1490-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

LIBERTY M. on 3/24/2021

Valencia N. on 8/2/2021

Melanie S. on 6/3/2022

Marti W. on 7/13/2022

Nicole F. on 8/28/2022

Carrie H. on 9/18/2022

Nicole G. on 9/23/2022

Kimber E. on 12/7/2022

Snehit P. on 10/23/2022

Travis V. on 11/13/2022

Brooke S. on 1/25/2023

Aroona S. on 1/30/2023

jubril o. on 2/7/2023

Jenna M. on 4/30/2023

Heather D. on 5/22/2023

Emily L. on 6/18/2023

Elizabeth P. on 7/16/2023

Sarah a. on 8/24/2023

Kelsey G. on 10/19/2023

Kim L. on 12/21/2023

Willliam F. on 12/23/2023

Meagan G. on 1/1/2024

Julia B. on 3/4/2024

Elizabeth M. on 3/14/2024

Duane B. on 3/31/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user